These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2007184)

  • 1. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.
    Leppä S; Härkönen P; Jalkanen M
    Cell Regul; 1991 Jan; 2(1):1-11. PubMed ID: 2007184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
    Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
    Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.
    Leppä S; Mali M; Miettinen HM; Jalkanen M
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):932-6. PubMed ID: 1736308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate.
    Borgenström M; Tienhaara A; Spillmann D; Salmivirta M; Jalkanen M
    Exp Cell Res; 2001 Apr; 264(2):307-14. PubMed ID: 11262187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.
    Leppä S; Vleminckx K; Van Roy F; Jalkanen M
    J Cell Sci; 1996 Jun; 109 ( Pt 6)():1393-403. PubMed ID: 8799827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of tumor cell growth by syndecan-1 ectodomain.
    Mali M; Andtfolk H; Miettinen HM; Jalkanen M
    J Biol Chem; 1994 Nov; 269(45):27795-8. PubMed ID: 7961703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
    Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
    Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the androgen-dependent MMTV-specific orf gene in Shionogi 115 mouse mammary tumor cells.
    Valve EM; Ruohola JK; Tasanen MJ; Glover JF; Darbre PD; Härkönen PL
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):389-400. PubMed ID: 11738549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells.
    Viklund L; Vorontsova N; Henttinen T; Salmivirta M
    Growth Factors; 2006 Jun; 24(2):151-7. PubMed ID: 16801134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
    Viklund L; Loo BM; Hermonen J; El-Darwish K; Jalkanen M; Salmivirta M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):146-52. PubMed ID: 11779146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
    Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
    Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factors induce 3T3 cells to express bFGF-binding syndecan.
    Elenius K; Määttä A; Salmivirta M; Jalkanen M
    J Biol Chem; 1992 Mar; 267(9):6435-41. PubMed ID: 1556147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.
    Munesue S; Kusano Y; Oguri K; Itano N; Yoshitomi Y; Nakanishi H; Yamashina I; Okayama M
    Biochem J; 2002 Apr; 363(Pt 2):201-9. PubMed ID: 11931647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells.
    Safaiyan F; Lindahl U; Salmivirta M
    Eur J Biochem; 1998 Mar; 252(3):576-82. PubMed ID: 9546676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells.
    Kirjavainen J; Leppä S; Hynes NE; Jalkanen M
    Mol Biol Cell; 1993 Aug; 4(8):849-58. PubMed ID: 8241570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
    Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
    Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan.
    Sanderson RD; Sneed TB; Young LA; Sullivan GL; Lander AD
    J Immunol; 1992 Jun; 148(12):3902-11. PubMed ID: 1602136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of syndecan-1 in malignancies.
    Inki P; Jalkanen M
    Ann Med; 1996 Feb; 28(1):63-7. PubMed ID: 8932508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
    Alexander CM; Reichsman F; Hinkes MT; Lincecum J; Becker KA; Cumberledge S; Bernfield M
    Nat Genet; 2000 Jul; 25(3):329-32. PubMed ID: 10888884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.